The gut microbiome in atherosclerotic cardiovascular disease

Nature Communications

Volumn 8, Issue 1, 2017, Pages

  Jie, Zhuye ^a,b   Xia, Huihua ^a,b   Zhong, Shi Long ^c   Feng, Qiang ^a,b,d,e,o   Li, Shenghui ^a   Liang, Suisha ^a,b   Zhong, Huanzi ^a,b,e   Liu, Zhipeng ^a,f   Gao, Yuan ^a,b   Zhao, Hui ^a   Zhang, Dongya ^a   Su, Zheng ^a   Fang, Zhiwei ^a   Lan, Zhou ^a   Li, Junhua ^a,b,g   Xiao, Liang ^a,b,d   Li, Jun ^a   Li, Ruijun ^h   Li, Xiaoping ^a,b   Li, Fei ^a,b,f   Ren, Huahui ^a   Huang, Yan ^a   Peng, Yangqing ^a,p   Li, Guanglei ^a   Wen, Bo ^a,b   Dong, Bo ^a   Chen, Ji Yan ^c   Geng, Qing Shan ^c   Zhang, Zhi Wei ^c   Yang, Huanming ^a,b,i   Wang, Jian ^a,b,i   Wang, Jun ^a,j,q   Zhang, Xuan ^k   Madsen, Lise ^a,b,e,l   Brix, Susanne ^m   Ning, Guang ⁿ   Xu, Xun ^a,b   Liu, Xin ^a,b   Hou, Yong ^a,b   Jia, Huijue ^a,b,j   He, Kunlun ^g,h   Kristiansen, Karsten ^a,b,e   more..

^a BGI SHENZHEN   (China)

^b BGI SHENZHEN   (China)

^c GUANGDONG PROVINCIAL PEOPLE'S HOSPITAL   (China)

^d Shenzhen Engineering Laboratory of Detection and Intervention of Human Intestinal Microbiome   (China)

^e UNIVERSITY OF COPENHAGEN   (Denmark)

^f UNIVERSITY OF CHINESE ACADEMY OF SCIENCES   (China)

^g SOUTH CHINA UNIVERSITY OF TECHNOLOGY   (China)

^h CHINESE PLA GENERAL HOSPITAL   (China)

ⁱ James D Watson Institute of Genome Sciences   (China)

^j MACAU UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Macao)

^k PEKING UNION MEDICAL COLLEGE HOSPITAL   (China)

^l INSTITUTE OF MARINE RESEARCH   (Norway)

^m TECHNICAL UNIVERSITY OF DENMARK   (Denmark)

ⁿ SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^o SHANDONG UNIVERSITY   (China)

^p WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^q Shandong Provincial Key Laboratory of Oral Tissue Regeneration ^*  (China)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ATORVASTATIN; CITRATE POTASSIUM; CLOPIDOGREL; FONDAPARINUX; HEPARIN; ISOSORBIDE DINITRATE; ISOSORBIDE MONONITRATE; METFORMIN; METOPROLOL; PERINDOPRIL; POTASSIUM CHLORIDE;

ABUNDANCE; BACTERIUM; CARDIOVASCULAR DISEASE; COHORT ANALYSIS; GENOME; METABOLISM;

ADULT; AGED; ARTICLE; BACTEROIDES UNIFORMIS; CLINICAL FEATURE; CLOSTRIDIUM PERFRINGENS; COHORT ANALYSIS; CONTROLLED STUDY; CORONARY ARTERY ATHEROSCLEROSIS; DIASTOLIC BLOOD PRESSURE; EGGERTHELLA LENTA; ENTEROBACTER AEROGENES; ESCHERICHIA COLI; GENOME-WIDE ASSOCIATION STUDY; HUMAN; INTESTINE FLORA; KLEBSIELLA; LACTOBACILLUS SALIVARIUS; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; METAGENOME; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; ORIBACTERIUM SINUS; RHEUMATOID ARTHRITIS; RUMINOCOCCUS; RUMINOCOCCUS GNAVUS; STREPTOCOCCUS; STREPTOCOCCUS PARASANGUINIS; SYSTOLIC BLOOD PRESSURE; YOUDEN INDEX; ATHEROSCLEROSIS; CASE CONTROL STUDY; DRUG EFFECTS; FERMENTATION; INFLAMMATION; METAGENOMICS; MICROBIOLOGY;

ENTEROBACTERIACEAE; STREPTOCOCCUS;

ATHEROSCLEROSIS; CASE-CONTROL STUDIES; FERMENTATION; GASTROINTESTINAL MICROBIOME; GENOME-WIDE ASSOCIATION STUDY; HUMANS; INFLAMMATION; LIVER CIRRHOSIS; METAGENOME; METAGENOMICS;

EID: 85031012310     PISSN: None     EISSN: 20411723     Source Type: Journal    
DOI: 10.1038/s41467-017-00900-1     Document Type: Article

References (62)

1. Aron-Wisnewsky, J. & Clement, K. The gut microbiome, diet, and links to cardiometabolic and chronic disorders. Nat. Rev. Nephrol. 12, 169-181 (2016).
2. Clemente, J. C., Ursell, L. K., Parfrey, L. W. & Knight, R. The impact of the gut microbiota on human health: an integrative view. Cell 148, 1258-1270 (2012).
3. Wang, J. & Jia, H. Metagenome-wide association studies: fine-mining the microbiome. Nat. Rev. Microbiol. 14, 508-522 (2016).
4. Qin, J. et al. A metagenome-wide association study of gut microbiota in type 2 diabetes. Nature 490,55-60 (2012).
5. Karlsson, F. H. et al. Gut metagenome in European women with normal, impaired and diabetic glucose control. Nature 498,99-103 (2013).
6. Forslund, K. et al. Disentangling type 2 diabetes and metformin treatment signatures in the human gut microbiota. Nature 528, 262-266 (2015).
7. Cotillard, A. et al. Dietary intervention impact on gut microbial gene richness. Nature 500, 585-588 (2013).
8. Le Chatelier, E. et al. Richness of human gut microbiome correlates with metabolic markers. Nature 500, 541-546 (2013).
9. Zeevi, D. et al. Personalized nutrition by prediction of glycemic responses. Cell 163, 1079-1094 (2015).
10. Karlsson, F. H. et al. Symptomatic atherosclerosis is associated with an altered gut metagenome. Nat. Commun. 3, 1245 (2012).
11. Wang, Z. et al. Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease. Nature 472,57-63 (2011).
12. Tang, W. H. et al. Intestinal microbial metabolism of phosphatidylcholine and cardiovascular risk. N. Engl. J. Med. 368, 1575-1584 (2013).
13. Koeth, R. A. et al. Intestinal microbiota metabolism of L-carnitine, a nutrient in red meat, promotes atherosclerosis. Nat. Med. 19, 576-585 (2013).
14. Wang, Z. et al. Non-lethal Inhibition of gut microbial trimethylamine production for the treatment of atherosclerosis. Cell 163, 1585-1595 (2015).
15. Ott, S. J. et al. Detection of diverse bacterial signatures in atherosclerotic lesions of patients with coronary heart disease. Circulation 113, 929-937 (2006).
16. Koren, O. et al. Human oral, gut, and plaque microbiota in patients with atherosclerosis. Proc. Natl Acad. Sci. USA 108, 4592-4598 (2011).
17. Lanter, B. B., Sauer, K. & Davies, D. G. Bacteria present in carotid arterial plaques are found as biofilm deposits which may contribute to enhanced risk of plaque rupture. MBio 5, e01206-e01214 (2014).
18. Li, J. et al. An integrated catalog of reference genes in the human gut microbiome. Nat. Biotechnol. 32, 834-841 (2014).
19. Nielsen, H. B. et al. Identification and assembly of genomes and genetic elements in complex metagenomic samples without using reference genomes. Nat. Biotechnol. 32, 822-828 (2014).
20. Prindiville, T., Cantrell, M. & Wilson, K. H. Ribosomal DNA sequence analysis of mucosa-associated bacteria in Crohn's disease. Inflamm. Bowel. Dis. 10, 824-833 (2004).
21. Willing, B. P. et al. A pyrosequencing study in twins shows that gastrointestinal microbial profiles vary with inflammatory bowel disease phenotypes. Gastroenterology 139, 1844-1854.e1 (2010).
22. Joossens, M. et al. Dysbiosis of the faecal microbiota in patients with Crohn's disease and their unaffected relatives. Gut 60, 631-637 (2011).
23. Dobkin, J. F., Saha, J. R., Butler, V. P., Neu, H. C. & Lindenbaum, J. Inactivation of digoxin by Eubacterium lentum, an anaerobe of the human gut flora. Trans. Assoc. Am. Phys. 95,22-29 (1982).
24. Haiser, H. J. et al. Predicting and manipulating cardiac drug inactivation by the human gut bacterium Eggerthella lenta. Science 341, 295-298 (2013).
25. Zhang, X. et al. The oral and gut microbiomes are perturbed in rheumatoid arthritis and partly normalized after treatment. Nat. Med. 21 , 895-905 (2015).
26. Scholz, M. et al. Strain-level microbial epidemiology and population genomics from shotgun metagenomics. Nat. Methods 13, 435-438 (2016).
27. Chen, L., Xiong, Z., Sun, L., Yang, J. & Jin, Q. VFDB 2012 update: toward the genetic diversity and molecular evolution of bacterial virulence factors. Nucleic Acids Res. 40, D641-D645 (2012).
28. Bader, M. W. et al. Recognition of antimicrobial peptides by a bacterial sensor kinase. Cell 122, 461-472 (2005).
29. Foerster, J. et al. The influence of whole grain products and red meat on intestinal microbiota composition in normal weight adults: a randomized crossover intervention trial. PLoS ONE 9, e109606 (2014).
30. Juraschek, S. P., Gelber, A. C., Choi, H. K., Appel, L. J. & Miller, E. R. Effects of the dietary approaches to stop hypertension (DASH) diet and sodium intake on serum uric acid. Arthritis Rheumatol. 11, 300-308 (2016).
31. Kanehisa, M., Goto, S., Sato, Y., Furumichi, M. & Tanabe, M. KEGG for integration and interpretation of large-scale molecular data sets. Nucleic Acids Res. 40, D109-D114 (2012).
32. Simon, N., Friedman, J., Hastie, T. & Tibshirani, R. A sparse-group lasso. J. Comput. Graph. Stat. 22, 231-245 (2013).
33. Clark, S. R. et al. Characterization of platelet aminophospholipid externalization reveals fatty acids as molecular determinants that regulate coagulation. Proc. Natl Acad. Sci. USA 110, 5875-5880 (2013).
34. Zhernakova, A. et al. Population-based metagenomics analysis reveals markers for gut microbiome composition and diversity. Science 352, 565-569 (2016).
35. Wu, H. et al. Metformin alters the gut microbiome of individuals with treatment-naive type 2 diabetes, contributing to the therapeutic effects of the drug. Nat. Med. 23, 850-858 (2017).
36. Bajaj, J. S. et al. Systems biology analysis of omeprazole therapy in cirrhosis demonstrates significant shifts in gut microbiota composition and function. Am. J. Physiol. Gastrointest. Liver Physiol. 307, G951-G957 (2014).
37. Imhann, F. et al. Proton pump inhibitors affect the gut microbiome. Gut 2015, 310376 (2015).
38. Jackson, M. A. et al. Proton pump inhibitors alter the composition of the gut microbiota. Gut 2015, 310861 (2015).
39. McArdle, B. H. & Anderson, M. J. Fitting multivariate models to community data: a comment on distance-based redundancy analysis. Ecology 82, 290-297 (2001).
40. Loria, C. M., Ingram, D. D., Feldman, J. J., Wright, J. D. & Madans, J. H. Serum folate and cardiovascular disease mortality among US men and women. Arch. Intern. Med. 160, 3258-3262 (2000).
41. Brix, S., Eriksen, C., Larsen, J. M. & Bisgaard, H. Metagenomic heterogeneity explains dual immune effects of endotoxins. J. Allergy Clin. Immunol. 135, 277-280 (2015).
42. Zhu, W. et al. Gut microbial metabolite TMAO enhances platelet hyperreactivity and thrombosis risk. Cell 165, 111-124 (2016).
43. Leonhartsberger, S., Korsa, I. & Bock, A. The molecular biology of formate metabolism in enterobacteria. J. Mol. Microbiol. Biotechnol. 4, 269-276 (2002).
44. Holmes, E. et al. Human metabolic phenotype diversity and its association with diet and blood pressure. Nature. 453, 396-400 (2008).
45. Goodrich, J. K. et al. Genetic determinants of the gut microbiome in UK twins. Cell Host. Microbe. 19, 731-743 (2016).
46. Qin, N. et al. Alterations of the human gut microbiome in liver cirrhosis. Nature 513,59-64 (2014).
47. Liu, R. et al. Gut microbiome and serum metabolome alterations in obesity and after weight-loss intervention. Nat. Med. 23, 859-868 (2017).
48. Yatsunenko, T. et al. Human gut microbiome viewed across age and geography. Nature 486, 222-227 (2012).
49. Cairns, L. S., Marlow, V. L., Bissett, E., Ostrowski, A. & Stanley-Wall, N. R. A mechanical signal transmitted by the flagellum controls signalling in Bacillus subtilis. Mol. Microbiol. 90,6-21 (2013).
50. Feng, Q. et al. Integrated metabolomics and metagenomics analysis of plasma and urine identified microbial metabolites associated with coronary heart disease. Sci. Rep. 6, 22525 (2016).
51. Legendre, P. & Anderson, M. J. Distance-based redundancy analysis: testing multispecies responses in multifactorial ecological experiments. Ecol. Monogr. 69, 1 (1999).
52. Patil, K. R. & Nielsen, J. Uncovering transcriptional regulation of metabolism by using metabolic network topology. Proc. Natl Acad. Sci. USA 102, 2685-2689 (2005).
53. Feng, Q. et al. Gut microbiome development along the colorectal adenoma-carcinoma sequence. Nat. Commun. 6, 6528 (2015).
54. Backhed, F. et al. Dynamics and stabilization of the human gut microbiome during the first year of life. Cell Host. Microbe. 17, 690-703 (2015).
55. Benjamini, Y. & Hochberg, Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J. R. Stat. Soc. Series B 57, 289-300 (1995).
56. Claesson, M. J. et al. Gut microbiota composition correlates with diet and health in the elderly. Nature 488, 178-184 (2016).
57. Craciun, S. & Balskus, E. P. Microbial conversion of choline to trimethylamine requires a glycyl radical enzyme. Proc. Natl Acad. Sci. USA 109, 21307-21312 (2012).
58. Zhu, Y. et al. Carnitine metabolism to trimethylamine by an unusual Rieske-type oxygenase from human microbiota. Proc. Natl Acad. Sci. USA 111 , 4268-4273 (2014).
59. Koeth, R. A. et al. γ-butyrobetaine is a proatherogenic intermediate in gut microbial metabolism ofL-carnitine to TMAO. Cell Metab. 20, 799-812 (2014).
60. Storey, J. D. A direct approach to false discovery rates. J. R. Stat. Soc. Series B Stat. Methodol. 64, 479-498 (2002).
61. Zapala, M. A. & Schork, N. J. Multivariate regression analysis of distance matrices for testing associations between gene expression patterns and related variables. Proc. Natl Acad. Sci. USA 103, 19430-19435 (2006).
62. Morgan, X. C. et al. Dysfunction of the intestinal microbiome in inflammatory bowel disease and treatment. Genome Biol. 13, R79 (2012).